SEALSQ CORP (LAES)
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
4DMT Announces New Employment Inducement Grants
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call